Skip to content
ContentLora

    Tip: press / anywhere to search.

    Explainer

    The NIH indirect cost cap fight explained

    On 7 February 2025 the National Institutes of Health (NIH) capped what its grants pay for indirect costs, the overhead that keeps research running, at 15%.[1] A federal court in Massachusetts blocked the cap nationwide, the First Circuit upheld that ruling on 5 January 2026, and the Justice Department let the April 2026 deadline to seek Supreme Court review pass.[2][3][4] Congress has also kept a long-standing ban on changing NIH's indirect-cost policy in the FY2026 spending law.[5]

    Editor reviewedStrict sourcingUpdated Explainer9 claims · 89% primaryHealth and medicine, Science, Courts and the law

    This page describes agency guidance, court rulings and reports by the Congressional Research Service (CRS) and others as of 2026-11-14 (UTC), and attributes each position to its source. The wider picture of US science budgets is covered in the guide to how research is funded.

    What indirect costs are

    Indirect costs, also called facilities and administrative costs, are expenses not specific to one research project that maintain the infrastructure and administrative support for federally funded research. Of the $33 billion NIH awarded in FY2024, 28% ($9.3 billion) went to them.[6]

    The 15% cap

    On 7 February 2025 NIH issued supplemental guidance setting a 15% rate for indirect costs on its grants. An annual appropriations provision has barred NIH from changing the indirect-cost policies in effect in the last quarter of FY2017.[1] NIH said the change was meant to send as many funds as possible to direct scientific research rather than administrative overhead.[6]

    The court rulings

    University associations, research institutions, the Association of American Medical Colleges and 22 state attorneys general sued. Judge Angel Kelley of the US District Court in Massachusetts blocked the cap with a nationwide preliminary injunction on 5 March 2025 and made it permanent in April 2025.[2]

    On 5 January 2026 a unanimous three-judge panel of the First Circuit upheld that ruling, holding that the district court had jurisdiction and that the cap violated a statute and NIH’s own regulations.[3] The panel relied on Justice Barrett’s August 2025 concurrence, which separated challenges to agency-wide policies, heard in district court, from claims for withheld grant money, which belong in the Court of Federal Claims.[7]

    The National Science Foundation tried a similar 15% rate. On 20 June 2025 Judge Indira Talwani, in the same court, vacated it as arbitrary and capricious and contrary to law.[8]

    How the fight ended

    The Justice Department let the April 2026 deadline pass without asking the Supreme Court to review the First Circuit ruling. The American Council on Education, one of the plaintiffs, said the litigation had concluded.[4]

    Congress has kept its own guardrail. The FY2026 appropriations law continued the ban on changing NIH’s indirect-cost policy.[5] According to the Council on Governmental Relations, NIH notice NOT-OD-26-072 says the law requires the indirect-cost provisions of 45 CFR Part 75 to keep applying to NIH awards.[9]

    Read next: Grant terminations, budget requests and NIH’s other funding changes are covered in how US science is funded and on the National Institutes of Health page.

    Questions readers ask

    What are indirect costs?

    Expenses not tied to one project that maintain research infrastructure and administrative support. Of the $33 billion NIH awarded in FY2024, 28% ($9.3 billion) went to indirect costs.[6]

    What did the NIH cap do?

    Supplemental guidance issued on 7 February 2025 set a 15% rate for indirect costs on NIH grants, even though an annual appropriations provision bars NIH from changing the indirect-cost policies in effect in late FY2017.[1]

    Did the cap ever take effect?

    Courts blocked it. A federal judge in Massachusetts issued a nationwide preliminary injunction on 5 March 2025 and made it permanent in April 2025, and the First Circuit upheld the ruling on 5 January 2026.[2][3]

    Did the government appeal to the Supreme Court?

    No. The Justice Department let the April 2026 deadline pass without asking the Supreme Court to review the First Circuit ruling. The American Council on Education, one of the plaintiffs, said the litigation had concluded.[4]

    Could a cap come back?

    The FY2026 appropriations law continued the ban on changing NIH's indirect-cost policy, and an NIH notice says the existing indirect-cost rules in 45 CFR Part 75 keep applying to NIH awards.[5][9]

    Sources

    · 9 claims from 8 publishers

    Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.

    1. [1]

      On 7 February 2025 NIH issued supplemental guidance capping reimbursement of indirect (facilities and administrative) costs on its grants at 15%, although an annual appropriations provision bars NIH from modifying the indirect-cost policies in effect in the last quarter of FY2017. confirmedas of 2026-04-17

    2. [2]

      A federal district court in Massachusetts (Judge Angel Kelley) blocked the indirect-cost cap with a nationwide preliminary injunction on 5 March 2025 and made it permanent in April 2025, in cases brought by university associations, research institutions, the Association of American Medical Colleges and 22 state attorneys general. confirmedas of 2026-05-18

    3. [3]

      On 5 January 2026 a unanimous three-judge panel of the First Circuit Court of Appeals upheld the ruling, holding that the district court had jurisdiction and that the cap violated a statute and NIH's regulations. confirmedas of 2026-01-07

    4. [4]

      The Justice Department let the April 2026 deadline pass without asking the Supreme Court to review the First Circuit ruling; the American Council on Education, one of the plaintiffs, said the litigation had concluded. confirmedas of 2026-04-13

    5. [5]

      The FY2026 appropriations law continued the ban on changing NIH's indirect-cost policy, limited funds for fully funded multiyear awards to the FY2025 level, and added a requirement to notify Congress after any termination or non-continuation of an HHS award. confirmedas of 2026-04-17

    6. [6]

      Indirect costs are expenses not specific to a research project that maintain research infrastructure and administrative support; of the $33 billion NIH awarded in FY2024, 28% ($9.3 billion) went to them, and NIH said the cap was meant to send as many funds as possible to direct research costs. confirmedas of 2026-04-17

    7. [7]

      The First Circuit relied on Justice Barrett's August 2025 concurrence, which distinguished challenges to agency-wide policies, heard in district court, from claims for withheld grant money, which belong in the Court of Federal Claims. confirmedas of 2026-01-07

    8. [8]

      NSF issued a policy notice (NSF 25-034) setting a standard 15% indirect-cost rate for universities; in a suit brought by university associations and research universities, on 20 June 2025 Judge Indira Talwani of the US District Court in Massachusetts vacated the rate and the notice and declared them invalid, arbitrary and capricious, and contrary to law. confirmedas of 2025-06-20

    9. [9]

      NIH notice NOT-OD-26-072, which the Council on Governmental Relations (COGR) circulated to members on 20 April 2026, states, according to COGR's summary, that the FY2026 appropriations law requires the indirect-cost provisions of 45 CFR Part 75 to continue to apply to NIH awards. confirmedas of 2026-04-20

    Revision history (1)
    1. Page created.

    Created Nov 14, 2026. Last reviewed by an editor on Nov 15, 2026. Next scheduled review: May 14, 2027.

    Cite this page

    "The NIH indirect cost cap fight explained." ContentLora, updated Nov 14, 2026. https://contentlora.com/explain/nih-indirect-cost-cap

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.